Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 214

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Neuroscience of Behavioral and Pharmacological Treatments for Addictions

Open access
Potenza, Marc N., Sofuoglu, Mehmet, Carroll, Kathleen M., Rounsaville, Bruce J. · 2011 · Neuron

Abstract

Summary Although substantial advances have been made in behavioral and pharmacological treatments for addictions, moving treatment development to the next stage may require novel ways of approaching addictions, particularly those derived from new findings regarding of the neurobiological underpinnings of addictions, while assimilating and incorporating relevant information from earlier approaches. In this review, we first briefly review theoretical and biological models of addiction and then describe existing behavioral and pharmacologic therapies for the addictions within this framework. We then propose new directions for treatment development and targets that are informed by recent evidence regarding the heterogeneity of addictions and the neurobiological contributions to these disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2011.02.009

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 176

  1. Achat-Mendes, 2010, Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: Studies with preferential antagonists in squirrel monkeys, J. Pharmacol. Exp. Ther., 334, 556, 10.1124/jpet.110.167619 · DOI
  2. Adewale, 2006, Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys, J. Pharmacol. Exp. Ther., 318, 922, 10.1124/jpet.106.105387 · DOI
  3. Alexander, 1990, Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions, Prog. Brain Res., 85, 119, 10.1016/S0079-6123(08)62678-3 · DOI · Paper page
  4. Andrews, 2010, Individuals family history positive for alcoholism show fMRI abnormalities in reward sensitivity that are related to impulsivity factors, Biol. Psychiatry
  5. Arias, 2008, Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers, Alcohol. Clin. Exp. Res., 32, 1159, 10.1111/j.1530-0277.2008.00735.x · DOI
  6. Baker, 2003, N-acetyl cysteine-induced blockade of cocaine-induced reinstatement, Ann. N. Y. Acad. Sci., 1003, 349, 10.1196/annals.1300.023 · DOI
  7. Balleine, 2007, Current trends in decision making, Ann. N. Y. Acad. Sci., 1104, xi, 10.1196/annals.1390.2226 · DOI
  8. Baptista, 2004, Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: Comparison between cocaine and a potent conventional reinforcer, J. Neurosci., 24, 4723, 10.1523/JNEUROSCI.0176-04.2004 · DOI · Paper page
  9. Bates, 2006, Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change, Psychol. Addict. Behav., 20, 241, 10.1037/0893-164X.20.3.241 · DOI · Paper page
  10. Bechara, 2003, Risky business: Emotion, decision-making, and addiction, J. Gambl. Stud., 19, 23, 10.1023/A:1021223113233 · DOI · Paper page
  11. Belin, 2008, High impulsivity predicts the switch to compulsive cocaine-taking, Science, 320, 1352, 10.1126/science.1158136 · DOI · Paper page
  12. Bell, 2001, Neurocognitive enhancement therapy with work therapy: Effects on neuropsychological test performance, Arch. Gen. Psychiatry, 58, 763, 10.1001/archpsyc.58.8.763 · DOI · Paper page
  13. Beveridge, 2008, Review. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 3257, 10.1098/rstb.2008.0102 · DOI
  14. Bickel, 2008, Temporal discounting as a measure of executive function: Insights from the competing neuro-behavioral decision system hypothesis of addiction, Adv. Health Econ. Health Serv. Res., 20, 289, 10.1016/S0731-2199(08)20012-9 · DOI
  15. Bisaga, 2010, A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period, Drug Alcohol Depend., 111, 97, 10.1016/j.drugalcdep.2010.04.006 · DOI
  16. Blanco, 2009, A pilot study of impulsivity and compulsivity in pathological gambling, Psychiatry Res., 167, 161, 10.1016/j.psychres.2008.04.023 · DOI
  17. Blum, 1996, Reward deficiency syndrome, Am. Sci., 84, 132
  18. Botvinick, 2001, Conflict monitoring and cognitive control, Psychol. Rev., 108, 624, 10.1037/0033-295X.108.3.624 · DOI · Paper page
  19. Brady, 2005, Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress, Am. J. Psychiatry, 162, 1483, 10.1176/appi.ajp.162.8.1483 · DOI · Paper page
  20. Brauer, 1997, High dose pimozide does not block amphetamine-induced euphoria in normal volunteers, Pharmacol. Biochem. Behav., 56, 265, 10.1016/S0091-3057(96)00240-7 · DOI · Paper page
  21. Brewer, 2008, Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients, Biol. Psychiatry, 64, 998, 10.1016/j.biopsych.2008.05.024 · DOI · Paper page
  22. Brewer, 2008, The treatment of pathologic gambling, Addict. Disorders Treatment, 7, 1, 10.1097/ADT.0b013e31803155c2 · DOI
  23. Brewer, 2008, The neurobiology and genetics of impulse control disorders: Relationships to drug addictions, Biochem. Pharmacol., 75, 63, 10.1016/j.bcp.2007.06.043 · DOI · Paper page
  24. Bymaster, 2002, Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder, Neuropsychopharmacology, 27, 699, 10.1016/S0893-133X(02)00346-9 · DOI · Paper page
  25. Cahill, 2010, Nicotine receptor partial agonists for smoking cessation, Cochrane Database Syst. Rev., 12, CD006103
  26. Carroll, 2004, Choosing a behavioral therapy platform for pharmacotherapy of substance users, Drug Alcohol Depend., 75, 123, 10.1016/j.drugalcdep.2004.02.007 · DOI
  27. Carroll, 2005, Behavioral therapies for drug abuse, Am. J. Psychiatry, 162, 1452, 10.1176/appi.ajp.162.8.1452 · DOI · Paper page
  28. Carroll, 1994, One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects, Arch. Gen. Psychiatry, 51, 989, 10.1001/archpsyc.1994.03950120061010 · DOI · Paper page
  29. Chamberlain, 2009, Atomoxetine modulates right inferior frontal activation during inhibitory control: A pharmacological functional magnetic resonance imaging study, Biol. Psychiatry, 65, 550, 10.1016/j.biopsych.2008.10.014 · DOI · Paper page
  30. Chambers, 2001, A neurobiological basis for substance abuse comorbidity in schizophrenia, Biol. Psychiatry, 50, 71, 10.1016/S0006-3223(01)01134-9 · DOI · Paper page
  31. Chambers, 2007, A scale-free systems theory of motivation and addiction, Neurosci. Biobehav. Rev., 31, 1017, 10.1016/j.neubiorev.2007.04.005 · DOI
  32. Chambers, 2003, Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability, Am. J. Psychiatry, 160, 1041, 10.1176/appi.ajp.160.6.1041 · DOI · Paper page
  33. Chen, 2010, Synaptic plasticity in the mesolimbic system: Therapeutic implications for substance abuse, Ann. N Y Acad. Sci., 1187, 129, 10.1111/j.1749-6632.2009.05154.x · DOI
  34. Cheon, 2008, The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia, Int. J. Neuropsychopharmacol., 11, 971, 10.1017/S1461145708008663 · DOI
  35. Childress, 1999, Limbic activation during cue-induced cocaine craving, Am. J. Psychiatry, 156, 11, 10.1176/ajp.156.1.11 · DOI · Paper page
  36. Costello, 2010, Effects of treatment for tobacco dependence on resting cerebral glucose metabolism, Neuropsychopharmacology, 35, 605, 10.1038/npp.2009.165 · DOI
  37. Culbertson, 2011, Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers, Arch. Gen. Psychiatry, 10.1001/archgenpsychiatry.2010.193 · DOI
  38. Cutler, 2005, Are alcoholism treatments effective? The Project MATCH data, BMC Public Health, 5, 75, 10.1186/1471-2458-5-75 · DOI
  39. Dalley, 2009, Dopamine receptors in the learning, memory and drug reward circuitry, Semin. Cell Dev. Biol., 20, 403, 10.1016/j.semcdb.2009.01.002 · DOI
  40. Dalley, 2011, Impulsivity, compulsivity, and top-down cognitive control, Neuron, 69, 680, 10.1016/j.neuron.2011.01.020 · DOI · Paper page
  41. Dalley, 2007, Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement, Science, 315, 1267, 10.1126/science.1137073 · DOI · Paper page
  42. deCharms, 2008, Applications of real-time fMRI, Nat. Rev. Neurosci., 9, 720, 10.1038/nrn2414 · DOI · Paper page
  43. DeRubeis, 1999, Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons, Am. J. Psychiatry, 156, 1007, 10.1176/ajp.156.7.1007 · DOI · Paper page
  44. Economidou, 2011, Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking, Biol. Psychiatry, 69, 266, 10.1016/j.biopsych.2010.09.040 · DOI
  45. Eisenberg, 2008, Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials, CMAJ, 179, 135, 10.1503/cmaj.070256 · DOI · Paper page
  46. Ersche, 2006, Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers, Psychopharmacology (Berl.), 188, 364, 10.1007/s00213-006-0515-z · DOI
  47. Ersche, 2007, The neuropsychology of amphetamine and opiate dependence: Implications for treatment, Neuropsychol. Rev., 17, 317, 10.1007/s11065-007-9033-y · DOI · Paper page
  48. Evans, 2007, A pilot double-blind treatment trial of memantine for alcohol dependence, Alcohol. Clin. Exp. Res., 31, 775, 10.1111/j.1530-0277.2007.00360.x · DOI
  49. Fong, 2008, A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers, Pharmacol. Biochem. Behav., 89, 298, 10.1016/j.pbb.2007.12.025 · DOI · Paper page
  50. Frascella, 2010, Shared brain vulnerabilities open the way for nonsubstance addictions: Carving addiction at a new joint?, Ann. N. Y. Acad. Sci., 1187, 294, 10.1111/j.1749-6632.2009.05420.x · DOI · Paper page
  51. Frewen, 2008, Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review, Clin. Psychol. Rev., 28, 228, 10.1016/j.cpr.2007.05.002 · DOI · Paper page
  52. George, 2010, Individual differences in prefrontal cortex function and the transition from drug use to drug dependence, Neurosci. Biobehav. Rev., 35, 232, 10.1016/j.neubiorev.2010.05.002 · DOI · Paper page
  53. George, 2002, A placebo controlled trial of bupropion for smoking cessation in schizophrenia, Biol. Psychiatry, 52, 53, 10.1016/S0006-3223(02)01339-2 · DOI · Paper page
  54. Ghahremani, 2011, Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals, Neuropsychopharmacology, 10.1038/npp.2010.233 · DOI
  55. Giacobini, 2004, Cholinesterase inhibitors: New roles and therapeutic alternatives, Pharmacol. Res., 50, 433, 10.1016/j.phrs.2003.11.017 · DOI · Paper page
  56. Glimcher, 2004, Neuroeconomics: The consilience of brain and decision, Science, 306, 447, 10.1126/science.1102566 · DOI · Paper page
  57. Goldapple, 2004, Modulation of cortical-limbic pathways in major depression: Treatment specific effects of cognitive behavioral therapy compared to paroxetine, Arch. Gen. Psychiatry, 61, 34, 10.1001/archpsyc.61.1.34 · DOI · Paper page
  58. Grant, 2008, Predicting response to opiate antagonists and placebo in the treatment of pathological gambling, Psychopharmacology (Berl.), 200, 521, 10.1007/s00213-008-1235-3 · DOI · Paper page
  59. Grant, 2009, Imaginal desensitisation plus motivational interviewing for pathological gambling: A randomised controlled trial, Br. J. Psychol., 195, 266, 10.1192/bjp.bp.108.062414 · DOI
  60. Grant, 2007, N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study, Biol. Psychiatry, 62, 652, 10.1016/j.biopsych.2006.11.021 · DOI · Paper page
  61. Grant, 2010, Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: A pilot study, Psychopharmacology (Berl.), 212, 603, 10.1007/s00213-010-1994-5 · DOI · Paper page
  62. Grant, 2010, Introduction to behavioral addictions, Am. J. Drug Alcohol Abuse, 36, 233, 10.3109/00952990.2010.491884 · DOI · Paper page
  63. Grohman, 2006, Improving treatment response of cognitively impaired veterans with neuropsychological rehabilitation, Brain Cogn., 60, 203
  64. Gual, 2001, Acamprosate during and after acute alcohol withdrawal: A double-blind placebo-controlled study in Spain, Alcohol Alcohol., 36, 413, 10.1093/alcalc/36.5.413 · DOI
  65. Hall, 2002, Psychological intervention and antidepressant treatment in smoking cessation, Arch. Gen. Psychiatry, 59, 930, 10.1001/archpsyc.59.10.930 · DOI · Paper page
  66. Haney, 2010, Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans, Biol. Psychiatry, 67, 59, 10.1016/j.biopsych.2009.08.031 · DOI
  67. Haney, 2001, Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans, Psychopharmacology (Berl.), 155, 330, 10.1007/s002130100725 · DOI · Paper page
  68. Harsan, 2008, Recovery from chronic demyelination by thyroid hormone therapy: Myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging, J. Neurosci., 28, 14189, 10.1523/JNEUROSCI.4453-08.2008 · DOI · Paper page
  69. Havassy, 2004, Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery, Am. J. Psychiatry, 161, 139, 10.1176/appi.ajp.161.1.139 · DOI
  70. Heidbreder, 2010, Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders, Ann. N. Y. Acad. Sci., 1187, 4, 10.1111/j.1749-6632.2009.05149.x · DOI · Paper page
  71. Herin, 2010, Agonist-like pharmacotherapy for stimulant dependence: Preclinical, human laboratory, and clinical studies, Ann. N. Y. Acad. Sci., 1187, 76, 10.1111/j.1749-6632.2009.05145.x · DOI
  72. Higgins, 1991, A behavioral approach to achieving initial cocaine abstinence, Am. J. Psychiatry, 148, 1218, 10.1176/ajp.148.9.1218 · DOI · Paper page
  73. Highfield, 2001, Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats, Neuropsychopharmacology, 25, 320, 10.1016/S0893-133X(01)00227-5 · DOI · Paper page
  74. Hogarty, 2004, Cognitive enhancement therapy for schizophrenia: Effects of a 2-year randomized trial on cognition and behavior, Arch. Gen. Psychiatry, 61, 866, 10.1001/archpsyc.61.9.866 · DOI · Paper page
  75. Holden, 2001, ‘Behavioral’ addictions: Do they exist?, Science, 294, 980, 10.1126/science.294.5544.980 · DOI · Paper page
  76. Holden, 2010, Psychiatry. Behavioral addictions debut in proposed DSM-V, Science, 327, 935, 10.1126/science.327.5968.935 · DOI · Paper page
  77. Horder, 2010, Reduced neural response to reward following 7 days treatment with the cannabinoid CB(1) antagonist rimonabant in healthy volunteers, Int. J. Neuropsychopharmacol., 13, 1103, 10.1017/S1461145710000453 · DOI
  78. Hu, 2010, Serotonin 1B receptor imaging in alcohol dependence, Biol. Psychiatry, 67, 800, 10.1016/j.biopsych.2009.12.028 · DOI
  79. Irvin, 1999, Efficacy of relapse prevention: A meta-analytic review, J. Consult. Clin. Psychol., 67, 563, 10.1037/0022-006X.67.4.563 · DOI · Paper page
  80. Jentsch, 2009, Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats, Psychopharmacology (Berl.), 202, 497, 10.1007/s00213-008-1181-0 · DOI
  81. Johansson, 2006, Efficacy of maintenance treatment with naltrexone for opioid dependence: A meta-analytical review, Addiction, 101, 491, 10.1111/j.1360-0443.2006.01369.x · DOI · Paper page
  82. Johnson, 2008, Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 209, 10.1016/j.pnpbp.2007.07.030 · DOI
  83. Johnson, 2010, Delay discounting in current and former marijuana-dependent individuals, Exp. Clin. Psychopharmacol., 18, 99, 10.1037/a0018333 · DOI · Paper page
  84. Kable, 2007, The neural correlates of subjective value during intertemporal choice, Nat. Neurosci., 10, 1625, 10.1038/nn2007 · DOI · Paper page
  85. Kampman, 2006, A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms, Drug Alcohol Depend., 85, 129, 10.1016/j.drugalcdep.2006.04.002 · DOI
  86. Kenny, 2011, Reward mechanisms in obesity: New insights and future directions, Neuron, 69, 664, 10.1016/j.neuron.2011.02.016 · DOI · Paper page
  87. Kim, 2006, A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder, Proc. Natl. Acad. Sci. USA, 103, 19164, 10.1073/pnas.0510836103 · DOI
  88. Knackstedt, 2009, The role of cystine-glutamate exchange in nicotine dependence in rats and humans, Biol. Psychiatry, 65, 841, 10.1016/j.biopsych.2008.10.040 · DOI · Paper page
  89. Knutson, 2008, Anticipatory affect: Neural correlates and consequences for choice, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 3771, 10.1098/rstb.2008.0155 · DOI · Paper page
  90. Kober, 2010, Prefrontal-striatal pathway underlies cognitive regulation of craving, Proc. Natl. Acad. Sci. USA, 107, 14811, 10.1073/pnas.1007779107 · DOI · Paper page
  91. Koob, 2010, Neurocircuitry of addiction, Neuropsychopharmacology, 35, 217, 10.1038/npp.2009.110 · DOI · Paper page
  92. Koob, 2010, Neurobiological mechanisms of addiction: Focus on corticotropin-releasing factor, Curr. Opin. Investig. Drugs, 11, 63
  93. Kosten, 2003, Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients, Drug Alcohol Depend., 70, 315, 10.1016/S0376-8716(03)00032-2 · DOI
  94. Kosten, 2006, Cue-induced brain activity changes and relapse in cocaine-dependent patients, Neuropsychopharmacology, 31, 644, 10.1038/sj.npp.1300851 · DOI · Paper page
  95. Krupitsky, 2007, Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients, Am. J. Psychiatry, 164, 519, 10.1176/ajp.2007.164.3.519 · DOI
  96. Lajtha, 2010, Heterogeneity of reward mechanisms, Neurochem. Res., 35, 851, 10.1007/s11064-009-0096-4 · DOI
  97. Lane, 2010, Diffusion tensor imaging and decision making in cocaine dependence, PLoS ONE, 5, e11591, 10.1371/journal.pone.0011591 · DOI
  98. Laucht, 2009, Impact of psychosocial adversity on alcohol intake in young adults: Moderation by the LL genotype of the serotonin transporter polymorphism, Biol. Psychiatry, 66, 102, 10.1016/j.biopsych.2009.02.010 · DOI
  99. Le Moal, 2009, Drug abuse: Vulnerability and transition to addiction, Pharmacopsychiatry, 42, S42, 10.1055/s-0029-1216355 · DOI
  100. LeSage, 2006, Current status of immunologic approaches to treating tobacco dependence: Vaccines and nicotine-specific antibodies, AAPS J., 8, E65, 10.1208/aapsj080108 · DOI
  101. Lewis, 2009, Learning sculpts the spontaneous activity of the resting human brain, Proc. Natl. Acad. Sci. USA, 106, 17558, 10.1073/pnas.0902455106 · DOI · Paper page
  102. Leyton, 2005, Cocaine craving, euphoria, and self-administration: A preliminary study of the effect of catecholamine precursor depletion, Behav. Neurosci., 119, 1619, 10.1037/0735-7044.119.6.1619 · DOI
  103. Li, 2006, Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence, Drug Alcohol Depend., 85, 205, 10.1016/j.drugalcdep.2006.04.008 · DOI · Paper page
  104. Li, 2010, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, 329, 959, 10.1126/science.1190287 · DOI · Paper page
  105. Liechti, 2007, Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence, J. Neurosci., 27, 9077, 10.1523/JNEUROSCI.1766-07.2007 · DOI · Paper page
  106. Lim, 2002, Reduced frontal white matter integrity in cocaine dependence: A controlled diffusion tensor imaging study, Biol. Psychiatry, 51, 890, 10.1016/S0006-3223(01)01355-5 · DOI · Paper page
  107. Lim, 2008, Brain macrostructural and microstructural abnormalities in cocaine dependence, Drug Alcohol Depend., 92, 164, 10.1016/j.drugalcdep.2007.07.019 · DOI
  108. Longo, 2010, Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence, Addiction, 105, 146, 10.1111/j.1360-0443.2009.02717.x · DOI · Paper page
  109. Lussier, 2006, A meta-analysis of voucher-based reinforcement therapy for substance use disorders, Addiction, 101, 192, 10.1111/j.1360-0443.2006.01311.x · DOI · Paper page
  110. Maddux, 2000, Addiction or dependence?, Addiction, 95, 661, 10.1046/j.1360-0443.2000.9556611.x · DOI
  111. Mann, 2004, Pharmacotherapy of alcohol dependence: A review of the clinical data, CNS Drugs, 18, 485, 10.2165/00023210-200418080-00002 · DOI · Paper page
  112. Martell, 2005, Vaccine pharmacotherapy for the treatment of cocaine dependence, Biol. Psychiatry, 58, 158, 10.1016/j.biopsych.2005.04.032 · DOI · Paper page
  113. Martelle, 2007, J. Pharmacol. Exp. Ther., 321, 573, 10.1124/jpet.106.113571 · DOI
  114. Martínez-Raga, 2008, Modafinil: A useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies, Curr Drug Abuse Rev, 1, 213, 10.2174/1874473710801020213 · DOI
  115. Mason, 2010, The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence, Expert Opin. Drug Saf., 9, 177, 10.1517/14740330903512943 · DOI
  116. Mattick, 2004, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst. Rev., CD002207
  117. McLellan, 1993, The effects of psychosocial services in substance abuse treatment, JAMA, 269, 1953, 10.1001/jama.1993.03500150065028 · DOI · Paper page
  118. Meda, 2009, Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis, Behav. Pharmacol., 20, 390, 10.1097/FBP.0b013e32833113a3 · DOI · Paper page
  119. Moeller, 2001, Psychiatric aspects of impulsivity, Am. J. Psychiatry, 158, 1783, 10.1176/appi.ajp.158.11.1783 · DOI · Paper page
  120. Moeller, 2005, Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: Diffusion tensor imaging, Neuropsychopharmacology, 30, 610, 10.1038/sj.npp.1300617 · DOI · Paper page
  121. Moeller, 2007, Diffusion tensor imaging eigenvalues: Preliminary evidence for altered myelin in cocaine dependence, Psychiatry Res., 154, 253, 10.1016/j.pscychresns.2006.11.004 · DOI
  122. Nasrallah, 2009, Long-term risk preference and suboptimal decision making following adolescent alcohol use, Proc. Natl. Acad. Sci. USA, 106, 17600, 10.1073/pnas.0906629106 · DOI · Paper page
  123. Nunes, 2004, Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis, JAMA, 291, 1887, 10.1001/jama.291.15.1887 · DOI · Paper page
  124. O'Brien, 2006, What's in a word? Addiction versus dependence in DSM-V, Am. J. Psychiatry, 163, 764, 10.1176/ajp.2006.163.5.764 · DOI · Paper page
  125. Olive, 2010, Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction, Eur. J. Pharmacol., 639, 47, 10.1016/j.ejphar.2010.01.029 · DOI
  126. Orson, 2008, Substance abuse vaccines, Ann. N Y Acad. Sci., 1141, 257, 10.1196/annals.1441.027 · DOI · Paper page
  127. Partilla, 2006, Interaction of amphetamines and related compounds at the vesicular monoamine transporter, J. Pharmacol. Exp. Ther., 319, 237, 10.1124/jpet.106.103622 · DOI
  128. Peirce, 2006, Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study, Arch. Gen. Psychiatry, 63, 201, 10.1001/archpsyc.63.2.201 · DOI · Paper page
  129. Peterson, 2009, An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD, Am. J. Psychiatry, 166, 1286, 10.1176/appi.ajp.2009.08050724 · DOI · Paper page
  130. Petry, 2001, Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates, J. Abnorm. Psychol., 110, 482, 10.1037/0021-843X.110.3.482 · DOI · Paper page
  131. Poling, 2006, Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population, Arch. Gen. Psychiatry, 63, 219, 10.1001/archpsyc.63.2.219 · DOI · Paper page
  132. Potenza, 2010, Control yourself: Alcohol and impulsivity, Alcohol. Clin. Exp. Res., 34, 1303, 10.1111/j.1530-0277.2010.01214.x · DOI
  133. Potenza, 2006, Should addictive disorders include non-substance-related conditions?, Addiction, 101, 142, 10.1111/j.1360-0443.2006.01591.x · DOI · Paper page
  134. Potenza, 2007, Impulse control disorders and co-occurring disorders: Dual diagnosis considerations, J. Dual Diagn., 3, 47, 10.1300/J374v03n02_06 · DOI
  135. Potenza, 2008, Review. The neurobiology of pathological gambling and drug addiction: An overview and new findings, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 3181, 10.1098/rstb.2008.0100 · DOI · Paper page
  136. Potenza, 2009, Non-substance and substance addictions, Addiction, 104, 1016, 10.1111/j.1360-0443.2009.02619.x · DOI
  137. Potenza, 2007, Sex differences in the neural correlates of stress and craving in cocaine dependence, J. Womens Health (Larchmt), 16, 1108
  138. Potenza, 2005, Shared genetic contributions to pathological gambling and major depression in men, Arch. Gen. Psychiatry, 62, 1015, 10.1001/archpsyc.62.9.1015 · DOI · Paper page
  139. Ray, 2008, Effects of naltrexone during the descending limb of the blood alcohol curve, Am. J. Addict., 17, 257, 10.1080/10550490802138400 · DOI
  140. Reissner, 2010, Using glutamate homeostasis as a target for treating addictive disorders, Behav. Pharmacol., 21, 514, 10.1097/FBP.0b013e32833d41b2 · DOI · Paper page
  141. Renthal, 2008, Epigenetic mechanisms in drug addiction, Trends Mol. Med., 14, 341, 10.1016/j.molmed.2008.06.004 · DOI · Paper page
  142. Reynolds, 2006, Dimensions of impulsive behavior: Personality and behavioral measures, Personality and Individual Differences, 40, 305, 10.1016/j.paid.2005.03.024 · DOI · Paper page
  143. Rutherford, 2010, Neurobiology of adolescent substance use disorders: Implications for prevention and treatment, Child Adolesc. Psychiatr. Clin. N. Am., 19, 479, 10.1016/j.chc.2010.03.003 · DOI
  144. Saxena, 2009, Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder, Mol. Psychiatry, 14, 197, 10.1038/sj.mp.4002134 · DOI · Paper page
  145. Schilström, 2007, Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors, Neuropsychopharmacology, 32, 43, 10.1038/sj.npp.1301087 · DOI
  146. Schlaug, 2009, Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy, Ann. N. Y. Acad. Sci., 1169, 385, 10.1111/j.1749-6632.2009.04587.x · DOI · Paper page
  147. Schmidt, 2010, Cocaine-induced neuroadaptations in glutamate transmission: Potential therapeutic targets for craving and addiction, Ann. N. Y. Acad. Sci., 1187, 35, 10.1111/j.1749-6632.2009.05144.x · DOI · Paper page
  148. Schultz, 2011, Potential effects of addictive drugs on neuronal reward, risk and decision mechanisms, Neuron, 69, 603, 10.1016/j.neuron.2011.02.014 · DOI · Paper page
  149. Seu, 2009, Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys, Psychopharmacology (Berl.), 202, 505, 10.1007/s00213-008-1250-4 · DOI
  150. Shearer, 2001, Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence, Addiction, 96, 1289, 10.1046/j.1360-0443.2001.96912898.x · DOI
  151. Shearer, 2003, Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence, Addiction, 98, 1137, 10.1046/j.1360-0443.2003.00447.x · DOI
  152. Sidhpura, 2010, Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence, Biol. Psychiatry, 67, 804, 10.1016/j.biopsych.2010.01.005 · DOI
  153. Sinha, 2008, Chronic stress, drug use, and vulnerability to addiction, Ann. N. Y. Acad. Sci., 1141, 105, 10.1196/annals.1441.030 · DOI · Paper page
  154. Sinha, 2009, Stress and addiction: A dynamic interplay of genes, environment, and drug intake, Biol. Psychiatry, 66, 100, 10.1016/j.biopsych.2009.05.003 · DOI
  155. Sinha, 2007, Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: Preliminary findings, Psychopharmacology (Berl.), 190, 569, 10.1007/s00213-006-0640-8 · DOI
  156. Sinha, 2005, Neural activity associated with stress-induced cocaine craving: A functional magnetic resonance imaging study, Psychopharmacology (Berl.), 183, 171, 10.1007/s00213-005-0147-8 · DOI · Paper page
  157. Sofuoglu, 2009, Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans, Psychopharmacology (Berl.), 207, 153, 10.1007/s00213-009-1643-z · DOI
  158. Srisurapanont, 2005, Naltrexone for the treatment of alcoholism: A meta-analysis of randomized controlled trials, Int. J. Neuropsychopharmacol., 8, 267, 10.1017/S1461145704004997 · DOI · Paper page
  159. Streeter, 2008, Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals, Neuropsychopharmacology, 33, 827, 10.1038/sj.npp.1301465 · DOI · Paper page
  160. Sulzer, 2011, How addictive drugs disrupt dopamine neurotransmission, Neuron, 69, 628, 10.1016/j.neuron.2011.02.010 · DOI · Paper page
  161. Tanabe, 2007, Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making, Hum. Brain Mapp., 28, 1276, 10.1002/hbm.20344 · DOI · Paper page
  162. Tolin, 2010, Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review, Clin. Psychol. Rev., 30, 710, 10.1016/j.cpr.2010.05.003 · DOI · Paper page
  163. Uhl, 2009, Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence, J. Neurogenet., 23, 272, 10.1080/01677060802572929 · DOI
  164. Uhl, 2004, The burden of complex genetics in brain disorders, Arch. Gen. Psychiatry, 61, 223, 10.1001/archpsyc.61.3.223 · DOI · Paper page
  165. Verdejo-García, 2008, Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies, Neurosci. Biobehav. Rev., 32, 777, 10.1016/j.neubiorev.2007.11.003 · DOI · Paper page
  166. Vocci, 2005, Medication development for addictive disorders: The state of the science, Am. J. Psychiatry, 162, 1432, 10.1176/appi.ajp.162.8.1432 · DOI · Paper page
  167. Volkow, 2004, Drug addiction: The neurobiology of behaviour gone awry, Nat. Rev. Neurosci., 5, 963, 10.1038/nrn1539 · DOI · Paper page
  168. Volkow, 2011, Addiction: Pulling at the neural threads of society, Neuron, 69, 599, 10.1016/j.neuron.2011.01.027 · DOI · Paper page
  169. Volkow, 2009, Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications, JAMA, 301, 1148, 10.1001/jama.2009.351 · DOI · Paper page
  170. Wang, 2009, Imaging of brain dopamine pathways: Implications for understanding obesity, J. Addict. Med., 3, 8, 10.1097/ADM.0b013e31819a86f7 · DOI · Paper page
  171. Weintraub, 2010, Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients, Arch. Neurol., 67, 589, 10.1001/archneurol.2010.65 · DOI · Paper page
  172. Wexler, 2001, Functional magnetic resonance imaging of cocaine craving, Am. J. Psychiatry, 158, 86, 10.1176/appi.ajp.158.1.86 · DOI · Paper page
  173. Wexler, 2011, Computerized cognitive remediation treatment for substance abuse disorders, Biol. Psychiatry, 69, 197, 10.1016/j.biopsych.2010.11.016 · DOI
  174. Wrase, 2007, Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics, Neuroimage, 35, 787, 10.1016/j.neuroimage.2006.11.043 · DOI · Paper page
  175. Xu, 2010, White matter integrity is associated with treatment outcome measures in cocaine dependence, Neuropsychopharmacology, 35, 1541, 10.1038/npp.2010.25 · DOI
  176. Zack, 2007, A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers, Neuropsychopharmacology, 32, 1678, 10.1038/sj.npp.1301295 · DOI · Paper page

Cited by

See all 214

Metadata

Authors
Potenza, M. N., Sofuoglu, M., Carroll, K. M., & Rounsaville, B. J.
Venue
Neuron
Publisher
Elsevier BV
Published
2011-02
Volume
69
Issue
4
Pages
695-712
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2019758887
Cited by
214
References
72
FWCI
9.65
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.